Trials of sickle cell anemia treatments underway

06/17/2013 | San Diego Union-Tribune

Recruitment has begun for a midstage clinical trial to find out whether heart disease drug Lexiscan can alleviate attacks of sickle cell anemia. The NIH-supported study will test whether the drug can relieve pain and inflammation. Meanwhile, HemaQuest has completed the recruitment of patients with sickle cell disease for a Phase IIb study involving HQK-1001, which promotes the production of fetal hemoglobin.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID